Papa Medical：2025年季度报告

FORM10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period endedJune 30,2025 OR ☐TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to _________ Commission file number:333-283405 Papa Medical Inc.(Exact name of registrant as specified in its charter) 202 North California AveCity of Industry,CA91744(626)855-0800(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices) Hua Yao, Chief Financial OfficerPapa Medical Inc.202 North California AveCity of Industry, CA91744(657)221-8185(Name, address, including zip code, and telephone number, including area code, of agent for service) Securities registered pursuant to Section 12(b) of the Act: Name of Each Exchange on WhichRegistered Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of“large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” as defined in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ As of September 25, 2025, there were(i)7,634,560shares of Class A common stock outstanding and (ii)12,365,440shares of Class Bcommon stock outstanding. FORWARD-LOOKING STATEMENTS This report contains forward-looking statements regarding our business, financial condition, results of operations and prospects. Wordssuch as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of suchwords are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifyingforward-looking statements as denoted in this report. Additionally, statements concerning future matters are forward-lookingstatements. Although forward-looking statements in this report reflect the good faith judgment of our management, such statements can only bebased on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks anduncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by theforward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, withoutlimitation, those specifically addressed under Part I, Item 1A, “Risk Factors” and Part II, Item 7, “Management’s Discussion andAnalysis of Financial Condition and Results of Operations” of our Registration Statement on Form S-1 filed on August 7, 2025, asdeclared effective by the SEC on August 12, 2025, as well as the headings “Risks Factors” and “Management’s Discussion andAnalysis of Financial Condition and Results of Operations” in this Form 10-Q and in other reports that we file with the U.S. Securitiesand Exchange Commission (the “SEC”). You are urged not to place undue reliance on these forward-looking statements, which speakonly as of the date of this report. We file reports with the SEC. The SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements,and other information regarding issuers that file electronically with the SEC, including us. You can also read and copy any materialswe file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You can obtain additionalinformation about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that mayarise after the date of this report, except as required by law. Readers are urged to carefully review and consider the various disclosuresmade throughout the entirety of this quarter